Recombinant factor VIII in hemophilia.
Cohen
A
A
Butler
R
R
D003365:Costs and Cost Analysis; D005169:Factor VIII / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use
D011994:Recombinant Proteins; D005169:Factor VIII